Year: 2018
Type: review
Abstract: Sterol regulator element binding proteins (SREBPs) are a family of transcription factors involved in the biogenesis of cholesterol, fatty acids and triglycerides. They also regulate physiological functions of many organs, such as thyroid, brain, heart, pancreas and hormone synthesis. Beside the physiological effects, SREBPs participate in some pathological processes, diabetes, endoplasmic reticulum stress, atherosclerosis and chronic kidney disease associated with SREBP expression changes. In the liver, SREBPs are involved in the pathogenesis of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatitis and hepatic cancer. There are several SREBP inhibitors that have potential for treating obesity, diabetes and cancer. This review assesses the recent findings about the roles of SREBPs in the physiology of organs' function and pathogenesis of liver diseases.
Authors: Azam Moslehi, Zeinab Hamidi-zad
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: SREBP, liver disease, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatitis, hepatocellular carcinoma, cholesterol biosynthesis, fatty acid synthesis, triglyceride synthesis, endoplasmic reticulum stress, diabetes mellitus, obesity, atherosclerosis, chronic kidney disease
Open Access status: diamond
OpenAlex ID: W2799783727
